Regenerace myokardu po intrakoronární aplikaci mononukleárních buněk kostní dřeně u pacientů s akutním infarktem s opožděnou reperfuzí a dysfunkcí levé komory

Myocardial regeneration after intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction and late reperfusion Objective and background: Despite the use of reperfusion therapies, outcomes in patients with large ST elevation...

Full description

Bibliographic Details
Main Author: Skalická, Hana
Other Authors: Horák, Jan
Format: Doctoral Thesis
Language:Czech
Published: 2011
Online Access:http://www.nusl.cz/ntk/nusl-299120
id ndltd-nusl.cz-oai-invenio.nusl.cz-299120
record_format oai_dc
spelling ndltd-nusl.cz-oai-invenio.nusl.cz-2991202018-10-03T04:29:35Z Regenerace myokardu po intrakoronární aplikaci mononukleárních buněk kostní dřeně u pacientů s akutním infarktem s opožděnou reperfuzí a dysfunkcí levé komory Myocardial regeneration after intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction and late reperfusion Skalická, Hana Horák, Jan Vojáček, Jan Málek, Ivan Myocardial regeneration after intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction and late reperfusion Objective and background: Despite the use of reperfusion therapies, outcomes in patients with large ST elevation myocardial infarction (STEMI), late reperfusion and left ventricular (LV) dysfunction is poor. We investigated longterm safety and efficacy of intracoronary injections of autologous bone marrow-derived mononuclear cells (BMNCs). Methods: 27 patients with anterior STEMI (age 59 ± 12 yrs, mean baseline LV ejection fraction (LVEF) 39±5%), who underwent percutaneous coronary intervention 4-24 hours after the onset of symptoms, were randomly assigned either to intracoronary BMNCs injection (n = 17, BMNCs group, out of which 14 underwent longterm follow-up), or to standard therapy (n = 10, Control group). The LVEF, the LV end-diastolic and end-systolic volumes (LVEDV, LVESV) and diastolic function (transmitral flow, pulmonary vein flow) were assessed by echocardiography at discharge, month 4 and 24. Myocardial perfusion was assessed using SPECT at baseline and month 4. Results: At 24-month, there was no difference in rates of serious clinical events (36% vs. 50%, p=0,54). At Month 4 LVEF improved to similar extent in... 2011 info:eu-repo/semantics/doctoralThesis http://www.nusl.cz/ntk/nusl-299120 cze info:eu-repo/semantics/restrictedAccess
collection NDLTD
language Czech
format Doctoral Thesis
sources NDLTD
description Myocardial regeneration after intracoronary injection of autologous bone marrow-derived mononuclear cells in patients with large anterior acute myocardial infarction and late reperfusion Objective and background: Despite the use of reperfusion therapies, outcomes in patients with large ST elevation myocardial infarction (STEMI), late reperfusion and left ventricular (LV) dysfunction is poor. We investigated longterm safety and efficacy of intracoronary injections of autologous bone marrow-derived mononuclear cells (BMNCs). Methods: 27 patients with anterior STEMI (age 59 ± 12 yrs, mean baseline LV ejection fraction (LVEF) 39±5%), who underwent percutaneous coronary intervention 4-24 hours after the onset of symptoms, were randomly assigned either to intracoronary BMNCs injection (n = 17, BMNCs group, out of which 14 underwent longterm follow-up), or to standard therapy (n = 10, Control group). The LVEF, the LV end-diastolic and end-systolic volumes (LVEDV, LVESV) and diastolic function (transmitral flow, pulmonary vein flow) were assessed by echocardiography at discharge, month 4 and 24. Myocardial perfusion was assessed using SPECT at baseline and month 4. Results: At 24-month, there was no difference in rates of serious clinical events (36% vs. 50%, p=0,54). At Month 4 LVEF improved to similar extent in...
author2 Horák, Jan
author_facet Horák, Jan
Skalická, Hana
author Skalická, Hana
spellingShingle Skalická, Hana
Regenerace myokardu po intrakoronární aplikaci mononukleárních buněk kostní dřeně u pacientů s akutním infarktem s opožděnou reperfuzí a dysfunkcí levé komory
author_sort Skalická, Hana
title Regenerace myokardu po intrakoronární aplikaci mononukleárních buněk kostní dřeně u pacientů s akutním infarktem s opožděnou reperfuzí a dysfunkcí levé komory
title_short Regenerace myokardu po intrakoronární aplikaci mononukleárních buněk kostní dřeně u pacientů s akutním infarktem s opožděnou reperfuzí a dysfunkcí levé komory
title_full Regenerace myokardu po intrakoronární aplikaci mononukleárních buněk kostní dřeně u pacientů s akutním infarktem s opožděnou reperfuzí a dysfunkcí levé komory
title_fullStr Regenerace myokardu po intrakoronární aplikaci mononukleárních buněk kostní dřeně u pacientů s akutním infarktem s opožděnou reperfuzí a dysfunkcí levé komory
title_full_unstemmed Regenerace myokardu po intrakoronární aplikaci mononukleárních buněk kostní dřeně u pacientů s akutním infarktem s opožděnou reperfuzí a dysfunkcí levé komory
title_sort regenerace myokardu po intrakoronární aplikaci mononukleárních buněk kostní dřeně u pacientů s akutním infarktem s opožděnou reperfuzí a dysfunkcí levé komory
publishDate 2011
url http://www.nusl.cz/ntk/nusl-299120
work_keys_str_mv AT skalickahana regeneracemyokardupointrakoronarniaplikacimononuklearnichbunekkostnidreneupacientusakutniminfarktemsopozdenoureperfuziadysfunkcilevekomory
AT skalickahana myocardialregenerationafterintracoronaryinjectionofautologousbonemarrowderivedmononuclearcellsinpatientswithlargeanterioracutemyocardialinfarctionandlatereperfusion
_version_ 1718759063971430400